Chronic heart failure: The role of primary care - Position paper of the European Forum for Pimary Care

Quality in Primary Care

Volumn 16, Issue 5, 2008, Pages 351-362

  Vilaseca, Josep ^a,b   Dedeu, Toni ^a   de Graaf, Pim ^b   Hobbs, Richard ^c   Muth, Christiane ^d   Mårtensson, Jan ^e   López Alcázar, Miguel ^f   Scherer, Martin ^g  

^a Barcelona Research Institute of Health and Social Services Assessment (BRIHSSA)   (Spain)

^b European Forum for Primary Care ^*  (Spain)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d GOETHE UNIVERSITY   (Germany)

^e JÖNKÖPING UNIVERSITY   (Sweden)

^f Centro de Salud la Chana   (Spain)

^g UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT;

ARTICLE; AWARENESS; BLOOD ANALYSIS; CLINICAL EVALUATION; CLINICAL TRIAL; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; DISEASE SEVERITY; DRUG USE; EARLY DIAGNOSIS; ELECTROCARDIOGRAPHY; EUROPE; HEALTH CARE MANAGEMENT; HEALTH CARE QUALITY; HEALTH PROGRAM; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INTEGRATED HEALTH CARE SYSTEM; LIFESTYLE MODIFICATION; LOW DRUG DOSE; MEDICAL INFORMATION; MORBIDITY; MORTALITY; PATIENT CARE; PATIENT COUNSELING; PATIENT EDUCATION; PATIENT MONITORING; PEPTIDE ANALYSIS; PHYSICAL ACTIVITY; POSITIVE END EXPIRATORY PRESSURE; PRACTICE GUIDELINE; PRIMARY HEALTH CARE; RISK FACTOR; SLEEP APNEA SYNDROME; THORAX RADIOGRAPHY; VACCINATION;

CHRONIC DISEASE; DELIVERY OF HEALTH CARE, INTEGRATED; EUROPE; HEART FAILURE; HUMANS; PATIENT EDUCATION AS TOPIC; PRIMARY HEALTH CARE; QUALITY ASSURANCE, HEALTH CARE;

EID: 56249088286     PISSN: 14791072     EISSN: 14791064     Source Type: Journal    
DOI: None     Document Type: Article

References (87)

1. McDonagh TA, Morrison CE, Lawrence A et al. Symptomatic and asymptomatic left ventricular systolic dysfunction in an urban population. The Lancet 1997; 350:829-33.
2. Davies MK, Hobbs FDR, Davis RC et al. Prevalence of left ventricular systolic dysfunction and CHF in the general population: main findings from the ECHOES (Echocardiographic Heart of England Screening) Study. The Lancet 358(9280):439-44.
3. SHAPE. Survey Results to the General Public. Annual Congress of the European Society of Cardiology, Vienna, September 2003.
4. Hobbs FDR. Primary care physicians: champions of or an impediment to optimal care of the patient with CHF? European Journal of Heart Failure 1999;1:11-15.
5. Newson LR. GP Shirley Medical Practice West Midlands UK. Diagnosing and managing CHF - 10 top tips. The New Generalist 2007;5(2):48-50.
6. Roccaforte R, Demers C, Baldassarre F, Teo KK and Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in CHF patients. A meta-analysis. European Journal of Heart Failure 2005;7(7): 1133-44.
7. Stewart S, Macintyre K, Hole DJ et al. More 'malignant' than cancer? Five year survival following a first admission for CHF. European Journal of Heart Failure 2001; 3:315-22.
8. MERIT-HF Study Group. Effect of metoprolol CR/XL in CHF: Metoprolol CR/ XL Randomised Intervention Trial in Congestive CHF (MERIT-HF). The Lancet 1999;353:2001-7.
9. Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with CHF. New England Journal of Medicine 1997;336:525-33.
10. RALES Investigators. Effectiveness of spironolactone added to an angiotensin-converting enzyme inhibitor and a loop diuretic for severe chronic congestive CHF (the Randomized Aldactone Evaluation Study [RALES]). American Journal of Cardiology 1996;78:902-7.
11. Domanski MJ. Beta-Blocker Evaluation of Survival Trial (BEST). Journal of the American College of Cardiology 2000;35(Suppl. A):202A.
12. Blackledge HM, Tomlinson J and Squire IB. Prognosis for patients newly admitted to hospital with CHF: survival trends in 12 220 index admissions in Leicestershire 1993-2001. Heart 2003;89:615-20.
13. Ho KK, Anderson KM, Kannel WB et al. Survival after the onset of congestive CHF in Framingham Heart Study subjects. Circulation 1993;88:107-15.
14. McDonagh TA, Cunningham AD, Morrison CE et al. Left ventricular dysfunction, natriuretic peptides, and mortality in an urban population. Heart 2001;86:21-6.
15. Cleland JGF, Gemmell, I, Khand A and Boddy A. Is the prognosis of CHF improving? European Journal of Heart Failure 1999;1:229-41.
16. Swedberg K, Cleland J, Dargie H et al; Task Force for the Diagnosis and Treatment of CHF of the European Society of Cardiology. Guidelines for the diagnosis and treatment of CHF: executive summary (update 2005): The Task Force of the Diagnosis and Treatment of CHF of the European Society of Cardiology. European Heart Journal 2005;26:1115-40.
17. Stewart AL, Greenfield S, Hays RD et al. Functional status and well-being of patients with chronic conditions. Results from the medical outcomes study. Journal of the American Medical Association 1989;262: 907-13.
18. Cline CM, Willenheimer RB, Erhardt LR et al. Health related quality of life in elderly patients with CHF. Scandinavian Cardiovascular Journal 1999;33(5):278-85.
19. Havranek EP, Ware MG and Lowes BD. Prevalence of depression in congestive CHF. American Journal of Cardiology 1999;84(3):348-50.
20. Scherer M, Stanske B, Wetzel D et al. Psychische Kosymptomatik von hausärztlichen Patienten mit Herzinsuffizienz. Herz 2006;31(4):347-54.
21. Scherer M, Himmel W, Stanske B et al. Psychological distress in primary care patients with heart failure: a longitudinal study. British Journal of General Practice 2007;57(543):801-7.
22. Murberg TA, Bru E, Svebak S, Tveteras R and Aarsland T. Depressed mood and subjective health symptoms as predictors of mortality in patients with congestive CHF: a two-year follow-up study. International Journal of Psychiatry in Medicine 1999;29(3):311-26.
23. Lavie P. Mortality in sleep apnoea syndrome: a review of the evidence. European Respiratory Review 2007;16:203-10.
24. Wang H, Parker JD, Newton GE et al. Influence of obstructive sleep apnea on mortality in patients with heart failure. Journal of the American College of Cardiology 2007;49(15):1625-31.
25. Oldenburg O, Lamp B, Faber L et al. Sleep-disordered breathing in patients with symptomatic heart failure: a contemporary study of prevalence in and characteristics of 700 patients. European Journal of Heart Failure 2007;9(3):251-7.
26. Le Jemtel TH and Jelic S. Seek and treat obstructive sleep apnea in heart failure. Journal of the American College of Cardiology 2007;49(15):1632-3.
27. Arzt M and Bradley TD. Treatment of sleep apnea in heart failure. American Journal of Respiratory and Critical Care Medicine 2006; 173 (12):1300-8.
28. Malone S, Liu PP, Holloway R et al. Obstructive sleep apnoea in patients with dilated cardiomyopathy: effects of continuous positive airway pressure. The Lancet 1991;338:1480-4.
29. Naughton MT, Liu PP, Bernard DC et al. Treatment of congestive heart failure and Cheyne-Stokes respiration during sleep by continuous positive airway pressure. American Journal of Respiratory and Critical Care Medicine 1995;151:92-7.
30. Naughton MT, Bernard DC, Liu PP, Rutherford R, Rankin F and Bradley TD. Effects of nasal CPAP on sympathetic activity in patients with heart failure and central sleep apnea. American Journal of Respiratory and Critical Care Medicine 1995;152:473-9.
31. Fonseca C. Diagnosis of CHF in primary care. Heart Failure Review 2006;11:95-170.
32. Petersen S, Rayner M and Wolstenholme H. Coronary Heart Disease Statistics: CHF supplement. Oxford: University of Oxford, 2002.
33. Cowie MR, Struthers AD, Wood DA et al. Value of natriuretic peptides in assessment of patients with possible new CHF in primary care. The Lancet 1997;350: 1349-53.
34. Cowie MJ, Wood DA, Coats A et al. Incidence and Aetiology of CHF in the General Population. Abstract no. 20, CHF Update 98, Glasgow, Scotland, 25-27 June 1998.
35. Davie AP, Francis CM, Love MP et al. Value of an electrocardiogram in identifying CHF due to left ventricular systolic dysfunction. BMJ 1996;312:222.
36. Pewsner D, Jüni P, Egger M et al. Accuracy of electrocardiography in diagnosis of left ventricular hypertrophy in arterial hypertension: systematic review. BMJ 2007;335:711.
37. Hobbs FDR, Davis RC, Roalfe AK et al. Reliability of N-terminal pro-brain natriuretic peptide assay in diagnosis of CHF: cohort study in representative and high risk community populations. BMJ2002; 324:1498-502.
38. Hobbs FDR, Roalfe AK, Davis RC, Hare R and Davies MK. Reliability of N-terminal proBNP (NT-proBNP) assay in diagnosing left ventricular systolic dysfunction within representative and high-risk populations. Heart 2004;90:866-70.
39. Doust JA, Glasziou PP, Pietrzak E and Dobson AJ. A systematic review of the diagnostic accuracy of natriuretic peptides for heart failure. Archives of Internal Medicine 2004;164:1978-84.
40. Craig J, Bradbury I, Cummins E et al. The use of B-type natriuretic peptides (BNP and NT-proBNP) in the investigation of patients with suspected heart failure. NHS Quality Improvement Scotland (NHS QIS). Health Technology Assessment Report 2005(6), www.nhshealthality.org/nhsqis/files/bnp_final_report.pdf 24 July 2008).
41. Koschack J, Scherer M, Luers C et al. Natriuretic peptide vs. clinical information for diagnosis of left ventricular systolic dysfunction in primary care. BMC Family Practice 2008;9:14.
42. Troughton R, Frampton C, Yandle T et al. Treatment of CHF guided by plasma aminoterminal brain natriuretic peptide (N-BNP) concentrations. The Lancet 2000;355: 1126-30.
43. Muth C, Gensichen J and Butzlaff M (2006) German Society for General Practice and Family Medicine. Heart Failure Guideline. [in German] Duesseldorf: Omikron Publishing, 2006. www.degam.de/leitlinien/ 9_herzinsuffizienzs.html (accessed 24 July 2008).
44. The National Collaborating Centre for Chronic Conditions. Chronic Heart Failure. National clinical guideline for diagnosis and management in primary and secondary care. NICE Guideline No. 5. London: National Institute for Health and Clinical Excellence, 2003.
45. Canadian Cardiovascular Society. The 2002/3 Canadian Cardiovascular Society Consensus Guideline, www.ccs.ca/download/ CCSHFConsUpdateDraft0103EMail.pdf (accessed 24 July 2008).
46. Institute for Clinical System Improvement. Health Care Guideline. Congestive Heart Failure in Adults, www.icsi.org/knowledge/ detail.asp?catID=29&itemID=161
47. The Finnish Medical Society Duodecim. Chronic Heart Failure. www.ebm-guidelines.com (accessed 24 July 2008).
48. Remme WJ and Swedberg K. Task Force for the Diagnosis and Treatment of Chronic Heart Failure, European Society of Cardiology: guidelines for the diagnosis and treatment of chronic heart failure. European Heart Journal 2001;22:1527-60. Erratum in European Heart Journal 2001;22:2217-18.
49. The National Heart Foundation of New Zealand. A Guideline for the Management of Heart Failure. www.nzgg.org.nz/guidelines/ dsp_guideline∝pup.cfm?guidelineCatID=32&guidelineID=26 (accessed 24 July 2008).
50. Chavey WE II, Blaum CS, Bleske BE et al. Guideline for the management of heart failure caused by systolic dysfunction: Part I. Guideline development, etiology and diagnosis. American Family Physician 2001;64:769-74. www.aafp.org/afp/20010901/769.pdf
51. Rich MW. Heart failure. Cardiology Clinics 1999;17:123-35.
52. Grady KL, Dracup K, Kennedy G et al. Team management of patients with heart failure: a statement for healthcare professionals from the Cardiovascular Nursing Council of the American Heart Association. Circulation 2000;102:2443-56.
53. Cleland JGF, Cohen-Solal A, Cosin J et al, for the IMPROVEMENT of Heart Failure Programme Committees and Investigators and the Study Group on Diagnosis of the Working Group on Heart Failure of The European Society of Cardiology. Management of heart failure in primary care (the IMPROVEMENT of Heart Failure Programme). An international survey. The Lancet 2002;360:1631-9.
54. Cleland JG, Swedberg K, Follath F et al. Study Group on Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 1: patient characteristics and diagnosis. European Heart Journal 2003;24(5):442-63.
55. The Study Group of Diagnosis of the Working Group on Heart Failure of the European Society of Cardiology, Komajda M, Follath F, Swedberg K et al. The EuroHeart Failure survey programme - a survey on the quality of care among patients with heart failure in Europe. Part 2: treatment. European Heart Journal 2003;24:464-74.
56. CIBIS-II Investigators and Committees. The Cardiac Insufficiency Bisoprolol Study II. The Lancet 1999;353: 9-13.
57. SOLVD Investigators. Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive CHF. New England Journal of Medicine 1991;325:293-302.
58. SOLVD Investigators. Effect of enalapril on mortality and the development of CHF in asymptomatic patients with reduced left ventricular ejection fractions. New England Journal of Medicine 1992;327:685-91.
59. Pitt B, White H, Nicolau J et al. EPHESUS Investigators. Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and CHF. Journal of the American College of Cardiology 2005;46: 425-31.
60. Juurlink DN, Mamdani MM et al. Rates of hyperkalemia after publication of the Randomized Aldactone Evaluation Study. New England Journal of Medicine 2004; 351:543-51.
61. Pfeffer MA, Swedberg K, Granger CB et al, for the CHARM Investigators and Committees. Effects of candesartan on mortality and morbidity in patients with CHF: the CHARM-Overall programme. The Lancet 2003;326(9386):759-66.
62. Clarke KW, Gray D and Hampton JR. Evidence of inadequate investigation and treatment of patients with CHF. British Heart Journal 1994;71:584-7.
63. Dracup K, Baker DW, Dunbar SB, Dacey RA, Brooks NH and Johnsson JC. Management of heart failure II. Counseling, education and lifestyle modifications. Journal of the American Medical Association 1994;272: 1442-6.
64. Bushnell FKL. Self-care teaching, for congestive heart failure patients. Journal of Gerontological Nursing 1992; 18(10):27-32.
65. Martens KH. The increasing role of nurses in the management of heart failure in the USA. In: Stewart S and Blue L (eds) Improving Outcomes in Chronic Heart Failure. London: BMJ Publishing, 2001.
66. Blue L and McMurray JJV. A specialist nurse-led, home-based intervention in Scotland. In: Stewart S and Blue L (eds) Improving Outcomes in Chronic Heart Failure. London: BMJ Publishing, 2001.
67. Mårtensson J, Karlsson J-E and Fridlund B. Male patients with congestive heart failure and their conception of the life situation. Journal of Advanced Nursing 1997;25:579-86.
68. Mårtensson J, Karlsson J-E and Fridlund B. Female patients with congestive heart failure: how they conceive the life situation. Journal of Advanced Nursing 1998; 28(6):1216-24.
69. Juenger J, Schellberg D, Kraemer S et al. Health related quality of life in patients with congestive heart failure: comparison with other chronic diseases and relation to functional variables. BMJ 2002;87:235-41.
70. Knox D, Mischke L and Williams RE. Heart failure patient and family education. In: Moser DK and Riegel B (eds) Improving Outcomes in Heart Failure, an Interdisciplinary Approach. Gaithersburg: Aspen Publishers, 2001.
71. Ekman I, Norberg A and Lundman B. An intervention aimed at reducing uncertainty in elderly patients with chronic heart failure. International Journal for Human Caring 2000;4:7-13.
72. Jaarsma T. Inter-professional team approach to patients with heart failure. Heart 2005;91:832-8.
73. Jaarsma T, Strömberg A, Mårtensson J and Dracup K. Development and testing of the European Heart Failure Self-Care Behaviour Scale. European Journal of Heart Failure 2003;5:363-70.
74. Willenheimer R, Erhardt L, Cline C, Rydberg E and Israelsson B. Exercise training in CHF improves quality of life and exercise capacity. European Heart Journal 1998;19:774-81.
75. Rich MW, Beckham V, Wittenberg C et al. A multidisciplinary intervention to prevent the readmission of elderly patients with congestive CHF. New England Journal of Medicine 1995;333:1190-5.
76. Wagner E, Davis C, Schaefer J, von Korff M and Austin B. A survey of leading chronic disease management programs: are they consistent with the literature? Managed Care Quarterly 1999;7:56-66.
77. Tsai A, Morton S, Mangione C and Keeler E. A meta-analysis of interventions to improve care for chronic illnesses. American Journal of Managed Care 2005;11: 478-88.
78. Bodenheimer T, Wang MC, Rundall TG et al. What are the facilitators and barriers in physician organizations' use of care management processes? Joint Commission Journal on Quality and Patient Safety 2004;30:505-14.
79. Starfield B. Primary Care. Balancing health needs, services and technology. Oxford: Oxford University Press, 1998.
80. Amstrong E. Disease management: state of the art and future directions. Clinical Therapeutics 1999;3:593-609.
81. Freeman DA, Britton ML, Letassy NA et al. Management of hyperlipidemia in a clinical pathway unit. Disease Management and Clinical Outcomes 1998;1:111-20.
82. Roccaforte R, Demers C, Baldassarre F, Teo KK and Yusuf S. Effectiveness of comprehensive disease management programmes in improving clinical outcomes in CHF patients. A meta-analysis. European Journal of Heart Failure 2005;7(7):1133-44.
83. Remme WJ and Sweedberg K. Guidelines for the diagnosis and treatment of CHF. European Heart Journal 2001;22:1527-60.
84. McDonald K, Conlon Cand Ledwidge M. Editorial. Disease management programs for CHF: not just for the 'sick' CHF population. European Journal of Heart Failure 2007;9:113-17.
85. Clark RA, Inglis SC, McAllister FA, Cleland JG and Steward S. Telemonitoring or structured telephone support programmes for patients with CHF: systematic review and meta-analysis. BMJ 2007;334(7600):942-50.
86. Fabrellas N, Dedeu T, Agramunt M et al. Barcelona Expert Patient Project: sharing decisions. Oral session 18th Wonca World Conference, Singapore 2007. (Various sources of information have been used in compiling this position paper. Data from different sources are collected in different ways and with different degrees of validity and reliability.)
87. www.ucr.uu.se/rikssvikt (accessed 24 July 2008).